2/26
02:34 pm
cytk
Rating for CYTK
Low
Report
Rating for CYTK
2/25
07:05 pm
cytk
Cytokinetics (CYTK) had its "neutral" rating reaffirmed by Bank of America Corporation.
Low
Report
Cytokinetics (CYTK) had its "neutral" rating reaffirmed by Bank of America Corporation.
2/25
05:32 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
2/25
05:32 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
2/20
09:23 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
2/20
09:23 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
1/28
08:39 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
1/28
08:39 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
1/28
08:03 am
cytk
Cytokinetics (NASDAQ:CYTK) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $87.00 price target on the stock.
Low
Report
Cytokinetics (NASDAQ:CYTK) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $87.00 price target on the stock.
1/21
10:17 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $95.00 price target on the stock.
Low
Report
Cytokinetics (NASDAQ:CYTK) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $95.00 price target on the stock.
1/21
10:17 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $95.00 price target on the stock.
Low
Report
Cytokinetics (NASDAQ:CYTK) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $95.00 price target on the stock.
1/21
09:46 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
1/21
09:46 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
1/21
09:08 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at B. Riley.
Low
Report
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at B. Riley.
1/21
09:08 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at B. Riley.
Low
Report
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at B. Riley.
1/20
09:47 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
12/23
10:14 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
12/23
10:14 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
12/22
01:07 pm
cytk
Cytokinetics (NASDAQ:CYTK) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Medium
Report
Cytokinetics (NASDAQ:CYTK) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/22
01:07 pm
cytk
Cytokinetics (NASDAQ:CYTK) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Medium
Report
Cytokinetics (NASDAQ:CYTK) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/22
09:22 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
12/22
09:22 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
12/22
08:27 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
12/22
08:27 am
cytk
Rating for CYTK
Low
Report
Rating for CYTK
12/22
08:07 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Cytokinetics (NASDAQ:CYTK) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.